Skip to contentK
Kewaunee Scientific Corp
K
KEQUKewaunee Scientific Corp Q1 2023 · 10-Q
Revenue$50.12M$50.12M+26.9% vs Q1 2022 Net Income-$747.00K-$747.00KN/M vs Q1 2022 EPS Diluted-$0.27-$0.27N/M vs Q1 2022 Gross Profit$6,196,000+9.2% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Kewaunee Scientific Corp · CIK 55529 · Engraved from SEC EDGAR
Operating Cash Flow$3,685,000N/M Free Cash Flowderived$3,295,000N/M Margins · derivedGross margin12.4%−2.0 pt vs Q1 2022
Operating margin-0.8%+2.0 pt vs Q1 2022
Net margin-1.5%+1.9 pt vs Q1 2022
ended Jul 31, 2022 · filed Sep 9, 2022 · 40 d after period end